Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.07.13	Earnings Watch For July 16 (GS, YHOO, CSX, KO, JNJ, SCHW) (RTTNews)
10.07.13	UCB'Kremers Gets FDA Approval For Extended Release Methylphenidate Hydrochloride (RTTNews)
14.09.12	Sandra E. Peterson wird Group Worldwide Chairman und Mitglied des Exekutivausschusses bei Johnson & Johnson (Newsaktuell)
17.07.12	42.000 Quadratmeter grüne Logistik / Johnson & Johnson GmbH und Kühne + Nagel: Gemeinsames Logistikzentrum in Duisburg feiert im Juli einjähriges Bestehen (BILD) (Newsaktuell)
02.07.12	Wasserkraft für den PC / Ab Juli bezieht die Johnson & Johnson GmbH im Neusser Firmengebäude zu 100 Prozent Ökostrom (BILD) (Newsaktuell)
09.03.12	Johnson & Johnson GmbH auf Platz sieben der besten deutschen Arbeitgeber / Das Unternehmen punktet erneut bei "Deutschlands beste Arbeitgeber" in der Kategorie 501 bis 2.000 Mitarbeiter (Newsaktuell)
15.10.09	Biosense Webster Receives FDA Clearance for the CARTO® 3 System (Businesswire)
24.09.09	NEVO™ Sirolimus-Eluting Coronary Stent Associated with Significantly Less Chest Pain at Six Months Than Taxus® Liberte® Stent (Businesswire)
21.09.09	2.25 MM CYPHER® Sirolimus-eluting Coronary Stent Approved by FDA (Businesswire)
19.05.09	NEVO™ Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus® Liberte® Stent in Pivotal Clinical Trial (Businesswire)
11.12.08	Emma and Aiden Are Top Baby Names of 2008 (Businesswire)
06.11.08	Omrix Biopharmaceuticals Announces Third Quarter 2008 Financial Results (Businesswire)
21.10.08	Omrix Biopharmaceuticals Announces Third Quarter 2008 Financial Results Date and Conference Call (Businesswire)
09.10.08	Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding (Businesswire)
11.08.08	Omrix Biopharmaceuticals Announces Second Quarter 2008 Financial Results (Businesswire)
14.05.08	European Study Initiated to Compare Sirolimus-eluting Stenting versus Balloon Angioplasty in Patients with Peripheral Artery Disease Below-the-Knee (Businesswire)
09.05.08	Omrix Biopharmaceuticals Announces First Quarter 2008 Financial Results (Businesswire)
09.04.08	NEJM Study Demonstrates Carotid Stenting with Embolic Protection is Comparable to Surgery (Businesswire)
27.03.08	OMRIX Biopharmaceuticals Initiates Phase II Clinical Trial for Fibrin Patch Product Candidate (Businesswire)
13.03.08	Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote (PR Newswire)
31.01.08	Mentor Reports Third Quarter Fiscal Year 2008 Financial Results (Businesswire)
19.09.07	Mentor Corporation Announces Shareholders' Meeting Results and Adjournment; Declares Quarterly Cash Dividend (Businesswire)
14.09.07	Seven Summits Research Releases Comments on YHOO, JNJ, KR, MON, and AEM (PR Newswire)
09.08.07	Johnson & Johnson Statement on Civil Complaint Against The American National Red Cross and Commercial Licensees (Businesswire)
08.08.07	J&J (NYSE: JNJ) Sues Red Cross Over Use of Red Cross Emblem (PR Newswire)
02.07.07	Mentor Announces Market Launch of NeoForm(TM) Dermis for Breast Reconstruction (Businesswire)
12.06.07	Johnson & Johnson Selects ArisGlobal as its Global Pharmacovigilance and Safety Partner (Businesswire)
20.12.06	Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare (PR Newswire)
17.11.06	Mentor Receives FDA Approval to Sell Its MemoryGel(TM) Breast Implants; Announces Conference Call to Discuss Approval (Businesswire)
21.09.06	Law Offices of John David Hart: New Ortho Evra Warnings Long Overdue; FDA Announcement Too Late for Woman Who Had Miscarriage, Many Others (PR Newswire)
12.09.06	RNAi-Pionier Craig Mello erhält als erster den 'Dr. Paul Janssen Award' für biomedizinische Forschung (PR Newswire)
05.09.06	Johnson & Johnson Sued Over Ortho Evra Damage; Texas Woman Says Drug Caused Life-Threatening Blood Clots, Miscarriage (PR Newswire)
21.07.06	Seven Summits Research Releases Comments on DELL, JNJ, COF, BBBY, and ATYT (PR Newswire)
30.06.06	Vertex Pharmaceuticals and Tibotec Pharmaceuticals, a Johnson & Johnson Company, Announce Plans for Global Health Initiative to Increase Worldwide Prevention, Diagnosis and Treatment of HCV (PR Newswire)
05.05.06	Janssen-Cilag reicht Antrag auf Marketing-Genehmigung für neue Behandlung von Schizophrenie in Europa ein (PR Newswire)
16.03.06	Dawson James Securities Upgrades Antares Pharma to Strong Buy With $4.00 Price Target (PR Newswire)
21.11.05	Mentor Corporation Proposes to Merge with Medicis in $2.2 Billion All Stock Transaction; Mentor Offers 0.62 Shares per Share of Medicis; Merger Creates Global Leader Focused on Aesthetic Medicine (Businesswire)
26.05.05	PURE. NATURAL. LONG LASTING. PURAGEN DERMAL FILLER LAUNCHED TODAY; Next-generation hyaluronic acid product - the benchmark in consumer cosmetic choices (Businesswire)
26.05.05	Mentor Launches New PURAGEN Hyaluronic Acid Based Dermal Filler Product in Europe (Businesswire)
02.05.05	Multimedia Available: Setting The Safe Example (Businesswire)
06.04.05	FDA Releases Information from Mentor's Silicone Gel Breast Implant Ap (Businesswire)
06.04.05	Results from National Survey of Breast Augmentation Patients Confirm D (Businesswire)
04.03.05	Multimedia Available: Basketball Star Alonzo Mourning Reaches Out to F (Businesswire)
23.02.05	Multimedia Available: KidneyResource.com: New Gateway to Best Science- (Businesswire)
18.02.05	Mentor Announces Changes to Board of Directors (Businesswire)
08.02.05	Multimedia Available: Winter Weather Survival Guide (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

21.11.24		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
21.11.24		Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester
21.11.24		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
21.11.24		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
21.11.24		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
21.11.24		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
21.11.24		SLI aktuell: Anleger lassen SLI letztendlich steigen

21.11.24

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

21.11.24

Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester

21.11.24

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

21.11.24

Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen

21.11.24

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

21.11.24

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone